Project Grant K08DE034852
Award Date
4/7/25
Completion Date
3/31/28
Dollars Obligated
$169K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This Project Grant award, valued at $496,567 and awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) on June 1, 2024, will support research to develop, validate, and implement advanced computational tumor phenotyping techniques to characterize head and neck squamous cell carcinoma (HNSCC) at multiple biological levels. The research involves high-throughput analysis of quantitative features from radiology images (radiomics) and digital pathology images...
This $701,699 federal Project Grant award from the National Institute of Dental and Craniofacial Research (CFDA 93.121 - Oral Diseases and Disorders Research) aims to advance understanding of the hybrid epithelial/mesenchymal (HEM) state and its impact on immune infiltration in head and neck squamous cell carcinoma (HNSCC). The primary awardee, The General Hospital Corporation (Massachusetts General Hospital), will utilize advanced imaging approaches to develop imaging-based biomarkers related...
This $659,936 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a comprehensive study on racial disparities in oral cavity squamous cell carcinoma (OSCC) between African American (AA) and European American (EA) patients. The key products and services to be delivered include: Conducting multi-scale analyses of 163 AA-OSCC and 836 EA-OSCC cases to evaluate clinical,...
This Project Grant award of $371,719 from the National Cancer Institute's Cancer Biology Research (CFDA 93.396) program is supporting research at the University of Pennsylvania to characterize a distinct population of head and neck squamous cell carcinoma (HNSCC) stromal progenitors and explore how they regulate tumor progression. The primary goals are to: 1) determine the role of GLI1+ stromal cells in supporting HNSCC progression and metastasis through lineage tracing and loss-of-function...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $317,000 project grant (CFDA No. 93.121 - Oral Diseases and Disorders Research) to Temple University to investigate the role of amplified protein kinases in head and neck squamous cell carcinoma (HNSCC) progression and therapy resistance. The 2-year project aims to test whether the protein kinase TNIK, which is amplified in 20% of HNSCC cases, sustains HNSCC cell proliferation and viability by activating focal...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $390,000 in funding to The Medical College of Wisconsin, Inc. (MCW) from April 1, 2025 to March 31, 2030. The funding will support research to leverage single-cell co-culture and gene expression profiling to identify tumor antigen-specific T cells in oral squamous cell carcinoma (OSCC). The key products and services...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) totaling $1,915,027 will support research to define the relationship between aging, extracellular matrix dynamics, and immune evasive signaling in head and neck squamous cell carcinoma (HNSCC). The research seeks to uncover novel, targetable mechanisms through which the mechanical properties of aged tissues contribute to...
This federal Project Grant award for $234,000.00, issued by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate the functional roles and mechanisms of the human microbiome in oral squamous cell carcinoma (OSCC) pathogenesis. The study aims to define OSCC-associated metagenomic and metabolomic signatures, and determine whether microbiota transfer from human OSCC cases to mouse...
This Project Grant award, provided by the National Cancer Institute under the Cancer Biology Research (CFDA 93.396) program, aims to investigate the biological mechanisms driving racial disparities in outcomes for head and neck cancer, particularly among Black patients. The $714,062 award will fund two main objectives over a period of 5 years: Developing a tailored RNA prognostic model to enhance survival predictions for early-stage oral cancer in Black populations, by identifying gene...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Program (CFDA 93.121) provides $732,513 to The University of Texas MD Anderson Cancer Center for the "HARVARD MD ANDERSON COLLABORATIVE TO REDUCE LYMPHATIC MORBIDITY IN HEAD AND NECK CANCER WITH ARTIFICIAL INTELLIGENCE (HARMONIC-AI)" project. The project aims to leverage computational imaging and AI to enhance early detection and risk...